Genes responding to Canakinumab therapy in SJIA are -inversely - disregulated in adult onset Still's disease. Issue 1 (December 2015) - Brachat, A; Feist, E; Behrens, F; Blank, N; Nirmala, NR; Specker, C; Witt, M; Zernicke, J; Martini, A; Junge, G